nach oben

Journal of Behavioral Medicine

Erschienen in:

31.10.2018

Perceived sensitivity to medicines, alcohol interactive toxicity beliefs, and medication adherence among people living with HIV who drink alcohol

verfasst von: Seth C. Kalichman, Rob Horne, Harold Katner, Dominica Hernandez

Erschienen in: Journal of Behavioral Medicine | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Erroneous beliefs that it is toxic to drink alcohol while taking antiretroviral therapies (ART) used for treating HIV infection, known as alcohol interactive toxicity beliefs, may at least in part account for ART nonadherence among alcohol drinkers. This study was conducted to test a conceptual framework to explain the effects of interactive toxicity beliefs on ART adherence. Computerized surveys were administered to 124 participants receiving HIV care in the southeastern US. Serial mediation model with perceived sensitivity to medicines predicting HIV viral load through three mediating variables: alcohol-ART interactive toxicity beliefs, alcohol-ART avoidance behaviors, and ART adherence. HIV viral load extracted from medical records. Perceived sensitivity to medicines predicted HIV viral load; greater perceptions of medication sensitivity predicted lower HIV viral loads. In addition, there was a significant indirect effect of the serial chain of interactive toxicity beliefs → avoidance behaviors → ART adherence, indicating partial mediation of the relationship between perceived sensitivity to medicines and higher HIV viral load. Perceived sensitivity to medicines provides a conceptual basis for the effects of alcohol-medication interactive toxicity beliefs on ART adherence. Interactive toxicity beliefs are modifiable and can be altered to prevent intentional ART nonadherence.

Ajzen, I., & Fishbein, M. (1980). Understanding attitudes and predicting social behavior. Englewood Cliffs, NJ: Prentice-Hall.

Altice, F., Mostashari, F., & Friedland, G. (2001). Trust and the acceptance of and adherence to antiretroviral therapy. Journal of Acquired Immune Deficiency Syndrome, 28, 47–58. https://doi.org/10.1097/00126334-200109010-00008 CrossRef

Bangsberg, D. R., Hecht, F. M., Charlebois, E. D., Chesney, M., & Moss, A. (2001). Comparing objective measures of adherence to HIV antiretroviral therapy: Electronic medication monitors and unannounced pill counts. AIDS and Behavior, 5, 275–281. https://doi.org/10.1023/a:1011396711486 CrossRef

Carrieri, M. P., Villes, V., Raffi, F., Protopopescu, C., Preau, M., Salmon, D., et al. (2007). Self-reported side-effects of anti-retroviral treatment among IDUs: A 7-year longitudinal study. International Journal of Drug Policy, 18, 288–295. https://doi.org/10.1016/j.drugpo.2007.01.014 CrossRefPubMed

CDC. (2016). Lifetime risk of HIV diagnosis. Retrieved 2016, from http://www.cdc.gov/nchhstp/newsroom/2016/croi-press-release-risk.html

Faasse, K., Grey, A., Horne, R., & Petrie, K. J. (2015). High perceived sensitivity to medicines is associated with higher medical care utilisation, increased symptom reporting and greater information-seeking about medication. Pharmacoepidemiol Drug Safety, 24, 592–599. https://doi.org/10.1002/pds.3751 CrossRef

Fatch, R., Emenyonu, N. I., Muyindike, W., Kekibiina, A., Woolf-King, S., & Hahn, J. A. (2017). Alcohol interactive toxicity beliefs and ART nonadherence among HIV-infected current drinkers in Mbarara, Uganda. AIDS and Behavior, 21, 1812–1824. https://doi.org/10.1007/s10461-016-1429-3 CrossRefPubMedPubMedCentral

Finitsis, D. J., Pellowski, J. A., Huedo-Medina, T. B., Fox, M. C., & Kalichman, S. C. (2016). Visual analogue scale (VAS) measurement of antiretroviral adherence in people living with HIV (PLWH): A meta-analysis. Journal of Behavioral Medicine, 39, 1043–1055. https://doi.org/10.1007/s10865-016-9770-6 CrossRefPubMed

Fritz, K., Morojele, N., & Kalichman, S. (2010). Alcohol: The forgotten drug in HIV/AIDS. Lancet, 376, 398–400. https://doi.org/10.1016/s0140-6736(10)60884-7 CrossRefPubMedPubMedCentral

Giordano, T. P., Guzman, D., Clark, R., Charlebois, E. D., & Bangsberg, D. (2004). Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clinical Trials, 5, 74–79. https://doi.org/10.1310/jfxh-g3x2-eym6-d6ug CrossRefPubMed

Gupta, K., & Horne, R. (2001). The influence of health beliefs on the presentation and consultation outcome in patients with chemical sensitivities. Journal of Psychosomatic Research, 50, 131–137. https://doi.org/10.1016/s0022-3999(00)00218-x CrossRefPubMed

Hayes, A. F. (2013). Model templates for PROCESS for SPSS and SAS. New York: Guilford Press.

Hayes, A. F., & Mathes, J. (2009). Computational procedures for probing interactions in OLS and logistic regression: SPSS and SAS implementations. Behavior Research Methods, 41, 929–936.CrossRef

Hendershot, C. S., Stoner, S. A., Pantalone, D. W., & Simoni, J. M. (2009). Alcohol use and antiretroviral adherence: Review and meta-analysis. Journal of Acquired Immune Deficiency Syndromes, 52, 180–202. https://doi.org/10.1097/qai.0b013e3181b18b6e CrossRefPubMed

Horne, R., Chapman, S. C., Parham, R., Freemantle, N., Forbes, A., & Cooper, V. (2013a). Understanding patients’ adherence-related beliefs about medicines prescribed for long-term conditions: A meta-analytic review of the Necessity-Concerns Framework. PLoS ONE, 8, e80633. https://doi.org/10.1371/journal.pone.0080633 CrossRefPubMedPubMedCentral

Horne, R., Cooper, V., Gellaitry, G., Date, H. L., & Fisher, M. (2007). Patients’ perceptions of highly active antiretroviral therapy in relation to treatment uptake and adherence: The utility of the necessity-concerns framework. Journal of Acquired Immune Deficiency Syndromes, 45, 334–341. https://doi.org/10.1097/qai.0b013e31806910e3 CrossRefPubMed

Horne, R., Faasse, K., Cooper, V., Diefenbach, M. A., Leventhal, H., Leventhal, E., et al. (2013b). The perceived sensitivity to medicines (PSM) scale: An evaluation of validity and reliability. British Journal of Health Psychology, 18, 18–30. https://doi.org/10.1111/j.2044-8287.2012.02071.x CrossRefPubMed

Horne, R., Weinman, J., & Hankins, M. (1999). The beliefs about medicines questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication. Psychology and Health, 14, 1–24. https://doi.org/10.1080/08870449908407311 CrossRef

International Advisory Panel on, HIV Care Continuum Optimization. (2015). IAPAC guidelines for optimizing the HIV care continuum for adults and adolescents. Journal of the International Association of Providers of AIDS Care, 14, S3–S34. https://doi.org/10.1177/2325957415613442 CrossRef

Jalbert, J. J., Quilliam, B. J., & Lapane, K. L. (2008). A profile of concurrent alcohol and alcohol-interactive prescription drug use in the US population. Journal of General Internal Medicine, 23, 1318–1323. https://doi.org/10.1007/s11606-008-0639-4 CrossRefPubMedPubMedCentral

Judd, C. M., & Kenny, D. A. (1981). Process analysis: Estimating mediation in treatment evaluations. Evaluation Review, 5, 602–619. https://doi.org/10.1177/0193841x8100500502 CrossRef

Kalichman, S. C., Amaral, C. M., Swetzes, C., Jones, M., Macy, R., Kalichman, M. O., et al. (2009a). A simple single-item rating scale to measure medication adherence: Further evidence for convergent validity. Journal of the International Association of Physicians in AIDS Care, 8, 367–374. https://doi.org/10.1177/1545109709352884 CrossRefPubMed

Kalichman, S. C., Amaral, C. M., White, D., Swetsze, C., Kalichman, M. O., Cherry, C., et al. (2012). Alcohol and adherence to antiretroviral medications: Interactive toxicity beliefs among people living with HIV. Journal of the Association of Nurses in AIDS Care, 23, 511–520. https://doi.org/10.1016/j.jana.2011.11.005 CrossRefPubMed

Kalichman, S. C., Amaral, C. M., White, D., Swetsze, C., Pope, H., Kalichman, M. O., et al. (2009b). Prevalence and clinical implications of interactive toxicity beliefs regarding mixing alcohol and antiretroviral therapies among people living with HIV/AIDS. AIDS Patient Care STDS, 23, 449–454. https://doi.org/10.1089/apc.2008.0184 CrossRefPubMedPubMedCentral

Kalichman, S. C., Grebler, T., Amaral, C. M., McNerey, M., White, D., Kalichman, M. O., et al. (2013). Intentional nonadherence to medications among HIV positive alcohol drinkers: Prospective study of interactive toxicity beliefs. Journal of General Internal Medicine, 28, 399–405.CrossRefPubMed

Kalichman, S. C., Kalichman, M. O., Cherry, C., Hoyt, G., Washington, C., Grebler, T., et al. (2015). Intentional medication nonadherence because of interactive toxicity beliefs among HIV-positive active drug users. Journal of Acquired Immune Deficiency Syndromes, 70, 503–509.CrossRefPubMed

Maisto, S. A., Conigliaro, J., McNeil, M., Kraemer, K., & Kelley, M. E. (2000). An empirical investigation of the factor structure of the AUDIT. Psychological Assessment, 12, 346–353. https://doi.org/10.1037//1040-3590.12.3.346 CrossRefPubMed

McCance-Katz, E. F., Gruber, V. A., Beatty, G., Lum, P. J., & Rainey, P. M. (2013). Interactions between alcohol and the antiretroviral medications ritonavir or efavirenz. Journal of Addiction Medicine, 7, 264–270. https://doi.org/10.1097/adm.0b013e318293655a CrossRefPubMedPubMedCentral

Nestoriuc, Y., Orav, E. J., Liang, M. H., Horne, R., & Barsky, A. J. (2010). Prediction of nonspecific side effects in rheumatoid arthritis patients by beliefs about medicines. Arthritis Care Research, 62, 791–799. https://doi.org/10.1002/acr.20160 CrossRefPubMedPubMedCentral

Pellowski, J. A., Kalichman, S. C., Kalichman, M. O., & Cherry, C. (2016). Alcohol-antiretroviral therapy interactive toxicity beliefs and daily medication adherence and alcohol use among people living with HIV. AIDS Care, 28, 963–970. https://doi.org/10.1080/09540121.2016.1154134 CrossRefPubMedPubMedCentral

Sankar, A., Wunderlich, T., Neufeld, S., & Luborsky, M. (2007). Sero-positive African Americans’ beliefs about alcohol and their Impact on anti-retroviral adherence. AIDS and Behavior, 11, 195–203. https://doi.org/10.1007/s10461-006-9144-0 CrossRefPubMedPubMedCentral

Saunders, J. B., Aasland, O. G., Babor, T. F., DeLaFuente, J. R., & Grant, M. (1993). Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption II. Addictions, 88, 791–804. https://doi.org/10.1111/j.1360-0443.1993.tb02093.x CrossRef

Simoni, J., Kurth, A. E., Pearson, C., Pantalone, D. W., Merrill, J., & Frick, P. (2006). Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management. AIDS and Behavior, 10, 227–331. https://doi.org/10.1007/s10461-006-9078-6 CrossRefPubMedPubMedCentral

US Census. (2017). Quick facts: Georgia. Available from the US Census https://www.census.gov/quickfacts/GA. Accessed September 1, 2017.

Titel: Perceived sensitivity to medicines, alcohol interactive toxicity beliefs, and medication adherence among people living with HIV who drink alcohol
verfasst von: Seth C. Kalichman
Rob Horne
Harold Katner
Dominica Hernandez
Publikationsdatum: 31.10.2018
Verlag: Springer US
Erschienen in: Journal of Behavioral Medicine / Ausgabe 3/2019
Print ISSN: 0160-7715
Elektronische ISSN: 1573-3521
DOI: https://doi.org/10.1007/s10865-018-9987-7

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2019

Out-of-home informal support important for medication adherence, diabetes distress, hemoglobin A1c among adults with type 2 diabetes

Do ultraviolet photos increase sun safe behavior expectations via fear? A randomized controlled trial in a sample of U.S. adults

Physical activity, sitting, and risk factors of cardiovascular disease: a cross-sectional analysis of the CARRS study

Patient and partner illness appraisals and health among adults with type 1 diabetes

Ambivalence over emotional expression and intrusive thoughts as moderators of the link between self-stigma and depressive symptoms among Chinese American breast cancer survivors